Susquehanna Fundamental Investments, LLC Innoviva, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $1.21 Million - $1.41 Million	-102,416 Reduced 75.4%	33,412 $442,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $598,599 - $784,727	51,559 Added 61.18%	135,828 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $377,814 - $444,543	-23,747 Reduced 21.98%	84,269 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $183,362 - $242,049	-14,040 Reduced 11.5%	108,016 $1.81 Million
Q2 2021 Aug 11, 2021	BUY	$11.45 - $13.96 $964,880 - $1.18 Million	84,269 Added 223.01%	122,056 $1.64 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $699,014 - $813,409	-63,202 Reduced 62.58%	37,787 $452,000
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $182,373 - $243,946	19,547 Added 24.0%	100,989 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $841,295 - $1.18 Million	81,442 New	81,442 $851,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.